Medscape3 小时
FDA Approves Topical Tapinarof for Atopic Dermatitis
In a subset of patients in a 48-week extension trial, the mean duration of the first treatment-free interval was ...
FiercePharma10 小时
FDA blesses atopic dermatitis label expansions for Organon's Vtama, Galderma's Nemluvio
The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD).
FDA Approves VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults ...
Organon's VTAMA (tapinarof) cream is a first-in-class therapy with new FDA approval for atopic dermatitis in adults and children aged 2 and older.
Singapore seeing more cases of moderate to severe eczema
KKH and the National Skin Centre say there are more such patients, but no recent studies have been done. Read more at ...
The American Journal of Managed Care23 小时
FDA Approves Tapinarof Cream 1% for Patients With Atopic Dermatitis
Patients beginning the trial with a vIGA-AD score of 1 or greater were treated with tapinarof cream 1% until complete disease ...